fda tirzepatide shortage update Update: Current Guidelines for Semaglutide and Compounding tirzepatide shortage 2025 FDA Says

There are reports of women who struggled for years with infertility and subsequently experienced surprise pregnancies resulting in Ozempic babies after taking GLP-1s for diabetes or obesity

It was a legal mandate triggered by a single administrative decision: the removal of tirzepatide from the FDA Drug Shortages Database on October 2, 2024

Contact us today to learn more about these innovative treatments and how we can tailor them to your health goals

Ipamorelin is a more selective GHRP due to its distinct mode of action, which may impact growth hormone patterns linked with its secretion in experimental models

There will be rare patients who are obese and/or have type 2 diabetes and either fail or have a contraindication to all the great systemic medicines we already have available to us